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The  present  study  focused  on  the  role  of exogenous  alpha  lipoic  acid  (ALA)  in amelioration
of  inorganic  arsenic  (iAs)  induced  effects  on  apoptosis  and  apoptosis  associated  pro-
teins in developing  rat  hippocampus.  NaAsO2 (1.5/2.0  mg/kg  bw)  alone  or  along  with  ALA
(70 mg/kg  bw)  was  administered  to rat  pups  (experimental  groups)  by  intraperitoneal  (i.p.)
route from  postnatal  day  (PND)  4–15.  Controls  received  no  treatment/distilled  water/ALA.
On  PND  16,  the  animals  were  perfusion  ﬁxed  and  the brains  were  processed  for  parafﬁn
embedding  (CV  and  TUNEL  staining)  and  cryopreservation  (immunohistochemistry).  The
fresh brain  tissue  was  used  for Western  blotting.  Signiﬁcant  increase  was  observed  in TUNEL
positive cells  and Bax  (pro-apoptotic  protein)  expression  in hippocampal  sub-regions  of  iAsBax
Bcl-2
Oxidative stress
Hippocampus
alone  treated  groups,  whereas  Bcl-2  expression  was  intensiﬁed  in  animals  receiving  ALA
with iAs.  Densitometric  analysis  (Western  blots)  revealed  optimal  restoration  of Bax and
Bcl-2 ratio  in  animals  receiving  ALA  with iAs, thereby  suggesting  the  protective  role  of ALA
in iAs  induced  developmental  neurotoxicity.
©  2015  Published  by  Elsevier  Ireland  Ltd. This  is  an  open  access  article  under  the CC
BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Arsenic (As) is present ubiquitously in the environment.
The vulnerability of the biological systems to inorganic
arsenic (iAs) induced toxicity is evident from documented
reports of carcinogenic manifestations, hyperkeratosis,
Abbreviations: ALA, alpha lipoic acid; iAs,  arsenic; Na2AsO2, sodium
arsenite; i.p., intraperitoneal; PND, post natal day; CV, cresyl violet;
TUNEL, TdT mediated dUTP biotin nick-end labeling; CA1, CA2, CA3, cornu
amonis subregions; DG, dentate gyrus.
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2214-7500/© 2015 Published by Elsevier Ireland Ltd. This is an open access
licenses/by-nc-nd/4.0/).neuropathies, functional deﬁcits of organ systems, etc. fol-
lowing exposure to iAs [1–4]. Millions of people worldwide
are reported to be at risk of getting exposed to iAs by drink-
ing water based on their inhabitation in areas adjacent
to industrialization units dealing with iAs [5,6]. A number
of iAs contaminated endemic areas have been identiﬁed
across the globe, with countries like India, Bangladesh,
Inner Mongolia, Taiwan, America (Michigan, Minnesota,
South Dakota, Oklahoma, Wisconsin) etc. being toppers
in the list [7].iAs induced neurotoxic effects have been
reported in human [8] as well as in animal studies [9].
Various reports in literature are suggestive of increased
susceptibility of the juvenile central nervous system (CNS)
to various environmental contaminants including iAs [10].
The severity of chemically induced pathological effects,
especially in the developing nervous system (showing pro-
longed immaturity), vary according to the developmental
 article under the CC BY-NC-ND license (http://creativecommons.org/
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tage at the time of exposure [11,12]. The extrinsic as well
s intrinsic environmental inﬂuences are likely to induce
tructural alterations and long lasting functional deﬁcits
n later life. The ability of arsenic to cross the blood–brain
arrier [13] and get accumulated in the brain tissue [14]
as previously been reported. This holds relevance since
ncertainty prevails with context to efﬁcacy of BBB during
eveloping period. The rapid brain growth period (RBGP)
xtends along early postnatal period in rodents whereas
n humans it extends from third trimester of pregnancy to
arly infancy [15]. During this period of rapid structural and
unctional reorganization, trillions of connections per day
re established. Accordingly, the nervous system shows
ncreased susceptibility during this period toward vari-
us environmental insults especially neurotoxicants [2],
hereby making the child population even more vulnera-
le to insult induced adverse effects both before and after
irth. The study carried out on Mexican children [16] living
n an area contaminated with iAs and Pb,  showed a sub-
tantial inﬂuence of iAs on their verbal abilities whereas the
ttention process was more sensitive to Pb exposure. There
re also reports of impaired cognitive function majorly
ssociated with iAs exposure in children living in areas con-
aminated by both iAs and Pb [17]. The role of plasticity of
he developing nervous system in determining the sever-
ty of insult induced adverse effects needs to be explored
n depth.
Induction of oxidative stress by toxic stimuli assumes
n important role in brain damage [18]. Under normal
hysiological conditions, the increased vulnerability of the
ervous system to oxidative damage is associated with
ts higher rate of oxygen consumption along with rich
olyunsaturated fatty acid content of neurolemma on one
and and the provision of lower levels of cellular defense
echanisms on the other [19]. The published data sug-
ests a direct link between insult induced oxidative stress
nd altered neuronal characteristics (synaptic plasticity,
ellular and dendritic morphology, neuronal networking,
tc.) whereas supplementation of antioxidants (vitamins
, E and C) has been reported to modulate the redox sys-
em under these circumstances [20]. These facts are of
aramount importance especially during the developmen-
al periods, when the above mentioned processes are going
n in full swing. Among various antioxidants, lipoic acid has
peciﬁc antioxidant role in the CNS based on its ability to
ross the blood–brain barrier and on its equal uptake by
he central and the peripheral nervous system [21–23]. In
ur earlier study [24], the role of lipoic acid in modulation
f oxidative stress markers and the subsequent reversal of
he functional deﬁcits to a substantial extent, was  reported
n the hippocampus of rats subjected to early postnatal
xposure to NaAsO2.
The present study was designed to determine the
meliorating role of antioxidant (-lipoic acid, ALA)
upplementation on adverse effects induced by iAs expo-
ure (PND 4–15) on rat hippocampus. The information
vailable till date regarding the protective role of antiox-
dants in arsenic induced developmental neurotoxicity
ontinues to be patchy and insufﬁcient. Also, the impor-
ance of translation of experimental toxicological studies
o human health continues to stay.orts 2 (2015) 78–87 79
2. Materials and methods
2.1. Animals and treatments
Approval for the experimental protocol was obtained
from the Institute Animal Ethical Committee (IAEC-
390/07). Timed pregnant Wistar rats, procured from
Experimental Animal Facility (AIIMS), were housed in
standard laboratory cages maintained in temperature
(20–24 ◦C) and humidity (50–60%) controlled environment
in a reverse 12 h light/dark cycle. The animals had free
access to standard rodent diet (Ashirwad Industries, India)
and water. For assessing the delivery status, the animals
were checked daily at 10 am and the day of delivery was
considered as postnatal day (PND) 0 for the pups. For ran-
dom distribution, the pups across litter groups were pooled
together (irrespective of sex) on PND 2 and distributed
among the lactating mothers [25], ensuring that the litter
size did not exceed six/lactating mother.
Group I (control group) – the animals received either no
treatment (Nc) or distilled water (Sc) or ALA alone (AO).
Group II (arsenic group) – the animals received 1.5 (IIa)
and 2.0 (IIb) mg/kg bw NaAsO2.
Group III (arsenic + ALA group) – the animals received
NaAsO2 and ALA (1.5 mg  and 70 mg/kg bw – IIIa) and
NaAsO2 and ALA (2.0 mg  and 70 mg/kg bw – IIIb).
NaAsO2 (chemical purity of >98.5%) and ALA were pro-
cured from Loba Chemicals (India) and Sigma Chemicals
(USA) respectively. LD50 of NaAsO2 when administered i.p.
in adult Wistar rats has been reported as 15.86 mg/kg bw
[26]. In the present study, 1.5 mg/kg bw NaAsO2 (equiv-
alent to 9.4%) was administered i.p., the effective dose
(ED) being 1/10th of LD50. The other dose (2.0 mg/kg bw)
was higher by 0.5 mg  than the ﬁrst dose. For the iAs + ALA
groups, the dosage of ALA (70 mg/kg bw) was adopted from
Shila et al. [18] and the substances were administered
with half an hour interval between the two. To ensure
the delivery of requisite amount of the substances and
their effective uptake in the system, the intraperitoneal
(i.p.) route was  chosen. The exposure period extended from
postnatal day (PND) 4–15, thereby covering the rapid brain
growth period (RBGP).
Twenty-four hours after the last injection, the animals
were anaesthetized and transcardially perfusion ﬁxed (4%
paraformaldehyde in 0.1 M PB). The brains were dissected
out and processed for parafﬁn embedding and cryopreser-
vation. A coronal orientation was maintained for serial
sectioning (Bregma – 3.2 mm to −3.8 mm)  [27]. Paraf-
ﬁn sections (7 m)  and cryocut sections (30 m)  were
subjected to routine CV, TUNEL and immunohistochem-
ical staining respectively. The fresh hippocampal tissue
obtained from animals sacriﬁced by cervical dislocation
was processed for immunoblotting.
2.2. TUNEL assayTUNEL (TdT-mediated dUTP biotin nick-end labeling)
staining is used for identifying DNA strand breaks by
labeling their free 3′-OH termini with dUTP (deoxyuridine
logy Rep80 S. Dixit et al. / Toxico
triphosphate nucleotides). TUNEL staining was carried
out following manufacturer’s protocol (Roche Diagnostics,
Germany). The deparafﬁnized hippocampal sections were
hydrated and incubated with proteinase-K (working solu-
tion – 30 g/ml) for 15 min  at room temperature (RT) and
rinsed thrice with 0.1 M phosphate buffer saline (PBS). The
sections were incubated in TUNEL reaction mixture (1:45)
(In Situ Cell Death Detection kit, POD, Roche) in humid
atmosphere at 37 ◦C for 60 min  in dark. After washing,
converter POD was added for signal conversion followed
by DAB (3,3′-diaminobenzidine) reaction in dark. In the
mounted sections, the intensely dark brown stained nuclei
were identiﬁed as TUNEL positive. Negative and positive
controls were processed simultaneously with omission of
enzyme in the TUNEL reaction mixture for the former and
incubation of sections with DNAse (Roche Diagnostics)
prior to TUNEL mixture for the later.
TUNEL stained sections showing various subregions of
Cornu Ammonis (CA1, CA3) and Dentate gyrus (DG) from
either hemisphere were examined under the microscope
(Nikon, E-6oo) ﬁtted with Digital Camera System (DS-Fil-
U2) and having attached Nikon Imaging Software (NIS
Elements-AR 3.10) [28]. The ﬁrst section was randomly
chosen followed by every seventh section (42 m)  and
a total of six sections per animal were analyzed [29]. A
measured rectangular frame (250 m × 40 m)  was super-
imposed (40×) on selected reference areas (three for CA1,
two for CA3 and one each for ectal (DGEC) and endal
(DGEN) limb of DG) for counting the neuronal proﬁles and
leaving the cell bodies along the left and the lower mar-
gin of the frame (Forbidden line rule [30]). For TUNEL
positive cells, dense dark brown nuclei were counted.
The mean of positive neurons in the reference areas was
taken as mean number of positive cells in that section and
the mean of six such sections was taken as mean num-
ber of positive cells (mean number of cells/mm2) of that
specimen [29].
2.3. Immunohistochemistry (Bax, Bcl-2)
Free ﬂoating immunohistochemical staining technique
was adopted for localizing the expression of apoptosis asso-
ciated proteins (Bax and Bcl-2). Cryocut coronal sections
(30 m)  were incubated with mouse monoclonal anti Bcl-
2 and anti Bax (Sigma, USA) for 72 h at 4 ◦C (1:50) followed
by further incubation with goat-anti mouse secondary
antibody (SC 2050, Immuno Cruz TM Staining System,
Santa Cruz) at 4 ◦C. The antigen–antibody bound sites
were visualized by 3,3′-diaminobenzidine (DAB) reaction
(VECTOR-DAB staining kit). The sections were dehydrated,
mounted and observed under the microscope. Negative and
positive controls were processed simultaneously by car-
rying out incubation with species-speciﬁc normal serum
instead of primary serum for the former and staining of
cerebellar sections for the later.
2.4. Western blot analysisWestern blot analysis was carried out to determine the
tissue levels of apoptosis associated proteins (Bax and Bcl-
2). Fresh hippocampal tissue was weighed and collectedorts 2 (2015) 78–87
in lysis buffer (300 l 1.0 M Tris–HCl; 15 l 0.5 mM EDTA,
1.5 ml  1.0 mM phenylmethyl-sulphonylﬂuoride (PMSF),
15 l proteases inhibitors cocktail). Following sonication
(VCX 500, Sonics, USA) of lysates, centrifugation (R280,
Remi) (4 ◦C, 30 min, 10,000 rpm) [31] was carried out.
The supernatant was used for protein estimation [32]. For
Western blot analysis, equal amount of protein (n = 6/sub
group) in buffer was  mixed with equal amount of sam-
ple buffer (50 mM  Tris–HCL with 25% glycerol and 10%
SDS) and resolved on 12% SDS polyacrylamide gels using
Gel Electrophoresis Apparatus (Mini PROTEAN Tetra Cell,
Bio-Rad, USA). After electrophoretically transferring the
separated proteins to nitrocellulose membranes (pore size
0.45) (Sigma Chemicals, USA), the gels were stained with
Coomassie Blue to ascertain their complete transfer. After
washing, the membranes were incubated in 3% BSA (bovine
serum albumin) for 2 h at RT for blocking nonspeciﬁc
binding [31] followed by incubation with speciﬁc mouse
monoclonal primary antibodies for Bcl-2 and Bax (Santa
Cruz, Biotechnology) at a dilution of 1:1000 (overnight,
4 ◦C). Further incubation with HRP – conjugated goat
– antimouse IgG (SC-2005, SantaCruz) (1:1000, 2 h, RT)
was  followed by treating the membranes with reaction
mixture (substrate 0.01% H2O2) and chromogen DAB (SK
4100, Vector lab). Immediate scanning and photography
was  carried out to eliminate any signal loss and the dif-
ferences in the background staining. Mouse monoclonal
-tubulin, 1:5000 (Abcam) was  used as a loading con-
trol. Quantity 1 software of Gel Documentation System
(Bio-Rad, USA) was used for densitometric analysis of the
blots.
2.5. Statistical analysis
The data presented as mean ± SD was  statistically ana-
lyzed by One Way  Analysis of Variance (ANOVA) followed
by Bonferroni correction using the software STATA 9.0
(College Station, TX, USA). P value <0.05 was  considered
signiﬁcant.
3. Results
3.1. CV staining
Since the observations pertaining to various parameters
were not signiﬁcantly different across the control groups,
the observations only of the normal control group (Nc) were
included for comparison. The CV stained sections of hip-
pocampus from control and experimental animals showed
intact layering pattern such as stratum oriens (SO), stratum
pyramidale (SP), stratum radiatum (SR), granule cell layer
(GCL), sub granular zone (SGZ) (Fig. 1). Well organized
pyramidal cells in SP of CA1, CA3 (Fig. 1A1, C1, A2 and
C2) and granule cells in GCL of Dentate Gyrus Ectal limb
(DGEC) (Fig. 1A3 and C3) were observed with preserved
structural integrity such as discernable Nissl substance
around the pale spherical/oval nuclei and adequate packing
density of cells. Disruption in structural integrity (disso-
lution of Nissl substance and decreased neuronal packing
density) of pyramidal cells (Fig. 1B1 and B2) and granule
S. Dixit et al. / Toxicology Reports 2 (2015) 78–87 81
Fig. 1. Photo micrographs of CV stained coronal sections of CA1, CA3 and DG (DGEC) from control (A1–A3); iAs alone (2.0 mg/kg bw) (B1–B3) and iAs
(2.0  mg/kg bw)  + ALA (C1–C3) treated groups showing well arranged 3–5 cell layer thick SP (Í) having cells with thin rim of cytoplasm around large
(  )/oval ( ) nuclei and 1–3 small nucleoli. Disruption of pyramidal cell layers in SP (1–3 cell layer thick- ), loosely packed pyramidal neurons (↖),
w  pyram
l
c
(
3
d
G
s
(
w
t
v
o
(
w
cith  shrunken nuclei (↔) (B1 and B2). SO – stratum oriens; SP – stratum
ayer;  SGZ – sub granule zone.
ells (Fig. 1B3) was evident in iAs alone treated groups
Table 1).
.2. TUNEL staining
The intense dark brown staining of nuclei of pyrami-
al and granule cells was observed in SP (CA1, CA3) and
CL (DGEC) of iAs alone treated animals (Fig. 2B1–B3). The
taining intensity of pyramidal and granule cell nuclei in SP
CA1, CA3) and GCL (DGEC) of iAs + ALA co-treated animals
as evidently lighter (Fig. 2C1–C3), being comparable to
hose of the controls (Fig. 2A1–A3). These qualitative obser-
ations were substantiated by quantitative estimation
f TUNEL positive cells/mm2 in hippocampal subregions
CA1, CA3, DG) of iAs alone treated groups (Table 2) which
as relatively higher than the number of such cells in ALA
otreated groups and the controls.idale; SR – stratum radiatum; ML  – molecular layer; GCL – granule cell
3.3. Bax expression
iAs induced Bax (pro-apoptotic factor) upregulation
was evident by intense expression in the perikarya and
dendritic processes of the pyramidal cells in SP of CA1,
CA3 (Fig. 3B1 and B2) and granule cells in GCL of DG
(Fig. 3B3). The upregulated Bax immunoreactivity was also
evident in neuronal perikarya dispersed through SO, SR
and SGZ. In hippocampal subregions (CA1, CA3, DG) of ani-
mal  groups co-treated with iAs and ALA, Bax expression
was less intense, being comparable to those of the controls
(Fig. 3C1–C3, A1–A3).
3.4. Bcl-2 expressionThe pyramidal and granule cells of various hippocam-
pal subregions (CA and DG) of iAs alone treated groups
presented an overall weak expression of BCl-2 (mainly
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Table 1
Mean neuronal number (number of neurons/mm2) of pyramidal neurons in CA1, CA3 and granule cells in DG (DGEC, DGEN), of hippocampus in the control
and  the experimental groups (PND 16).
Groups Mean ± SD
CA1 CA3 DGEC DGEN
Sc (n = 6) 6936.5 ± 971.48 2926.16 ± 241.95 9761.33± 1009.99 11,969.17 ±032.46
NaAsO21.5 (n = 6) 4077.16 ± 828.17
(p < 0.001*,b)
1976.66 ± 571.95
(p < 0.011*,b)
5919.66 ± 1277.48
(p < 0.001*,b)
7463.5 ± 1757.67
(p < 0.001*,b)
NaAsO22.0 (n = 6) 3710.66 ± 762.58
(p < 0.001*,c)
1810.33 ± 201.99
(p < 0.002*,c)
5922.83 ± 890.06
(p < 0.001*,c)
7175 ± 1295.94
(p < 0.001*,c)
NaAsO21.5 + ALA (n = 6) 6136.5 ± 961.55
(p < 0.009*,d)
2955.5 ± 481.75
(p < 0.008*,d)
9100 ± 1589.01
(p < 0.003*,d)
10,553 ± 1930.60
(p < 0.020*,d)
NaAsO22.0 + ALA (n = 6) 6099 ± 1029.96
(p < 0.002*,e)
2833.33 ± 477.60
(p < 0.005*,e)
9363.83 ± 1166.74
(p < 0.001*,e)
10,261 ± 1416.14
(p < 0.020*,e)
pa 0.0001* 0.0001* 0.0001* 0.0001*
a Results compared using one-way analysis of variance (ANOVA) followed by Bonferroni correction, CA1, CA3 and DG (pairwise comparison).
b Sc vs NaAsO21.5.
c Sc vs NaAsO22.0.
d NaAsO21.5 vs NaAsO21.5 + ALA.
e NaAsO22.0 vs NaAsO22.0 + ALA.
* p < 0.05, statistically signiﬁcant.
Fig. 2. Photo micrographs of TUNEL stained coronal sections of CA1, CA3 and DGEC from control (A1–A3); iAs alone (2.0 mg/kg bw) (B1–B3) and iAs + ALA
treated groups (C1–C3). Intensely stained dark brown TUNEL positive pyramidal neurons (↑) in SP (B1 and B2) and granule cells (→) in GCL (B3). Light
brown  staining in C1–C3 is comparable to A1–A3.
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Table  2
Number of TUNEL +ve cells/mm2 in CA1, CA3 and DG (DGEC, DGEN) of the control and the experimental groups (PND 16).
Groups Mean ± SD
CA1 CA3 DGEC DGEN
Sc (n = 5) 131.25 ± 11.13 123.69 ± 16.92 106.16 ± 16.97 111.33 ± 9.60
NaAsO21.5 (n = 5) 57.78 ± 4.97
(p < 0.001*,b)
58.80 ± 10.42
(p < 0.001*,b)
52.12 ± 6.34
(p < 0.001*,b)
57.81 ± 5.05
(p < 0.001*,b)
NaAsO22.0 (n = 5) 53.54 ± 3.75
(p < 0.001*,c)
55.66 ± 9.20
(p < 0.001*,c)
46.38 ± 5.32
(p < 0.001*,c)
49.81 ± 8.76
(p < 0.001*,c)
NaAsO21.5 + ALA (n = 5) 109.31 ± 11.61
(p < 0.001*,d)
110.59 ± 12.93
(p < 0.001*,d)
98.93 ± 5.47
(p < 0.001*,d)
102.5 ± 6.32
(p < 0.001*,d)
NaAsO22.0 + ALA (n = 5) 108.26 ± 19.65
(p < 0.001*,e)
105.96 ± 19.60
(p < 0.001*,e)
101.56 ± 11.37
(p < 0.001*,e)
103.84 ± 14.66
(p < 0.001*,e)
pa 0.0001* 0.0001* 0.0001* 0.0001*
a Results compared using one-way analysis of variance (ANOVA) followed by Bonferroni correction, CA1, CA3 and DG (pairwise comparison).
b Sc vs NaAsO21.5.
c Sc vs NaAsO22.0.
d NaAsO21.5 vs NaAsO21.5 + ALA.
e NaAsO22.0 vs NaAsO22.0 + ALA.
* p < 0.05, statistically signiﬁcant.
Fig. 3. Coronal sections of CA1, CA3 and DGEC from control (A1–A3); iAs alone (2.0 mg/kg bw)  (B1–B3) and iAs + ALA treated groups (C1–C3) showing
intense  expression of Bax in neuronal perikarya (→) and processes ( ) of pyramidal and granule cells in experimental groups (B1–B3). The intensity
of  Bax expression in C1–C3 is comparable to A1–A3.
84 S. Dixit et al. / Toxicology Reports 2 (2015) 78–87
As alone
 granule
clei (B3)Fig. 4. Coronal sections of CA1, CA3 and DGEC from control (A1–A3); i
intense  expression of Bcl-2 in pyramidal cell nuclei (→) (C1 and C2) and
faintly  expressed in pyramidal cell nuclei (B1 and B2) and granule cell nu
conﬁned to the nuclear region) with some predominance in
the SP (CA1) and a somewhat uniform distribution in SR, SP,
SO (CA3) (Fig. 4B1 and B2). Weak Bcl-2 expression was also
evident in SGZ and GCL (DGEN). However, Bcl-2 expres-
sion was more intense across hippocampal subregions of
animals co-treated with ALA and iAs,  the intensity being
comparable to that of the controls (Fig. 4C1–C3, A1–A3).
3.5. Western blotting
The immunoreactive bands for Bax and Bcl-2 were seen
corresponding to 23 and 29 kDa proteins respectively. In iAs
alone treated groups, the Bax expression was more intense
whereas in iAs and ALA co-treated groups, the intense
banding corresponded to BCl-2 expression. The densito-
metric analysis in the respective group bands showed a
signiﬁcant and marginally dose dependent increase in Bax
expression in iAs alone treated groups whereas enhanced
Bcl-2 expression was evident in the animals receiving ALA
with iAs (Fig. 5A2 and C2).
The Bax:Bcl-2 ratio based on densitometric values for all
bands presented a shift toward Bax (Bax ∼ 75%, Bcl-2 ∼ 25%)
in iAs alone treated groups, thus substantiating iAs induced (2.0 mg/kg bw)  (B1–B3) and iAs + ALA treated groups (C1–C3) showing
 cell nuclei (→) (C3), the intensity being comparable to A1–A3. Bcl-2 is
.
up-regulation of Bax. The shift in the anti and pro apoptotic
protein ratio toward Bcl-2 (Bcl-2 ∼ 66%, Bax ∼ 34%) in ani-
mals co-treated with iAs and ALA suggested ALA induced
upregulation of Bcl-2.
4. Discussion
While there are reports of iAs induced neuronal cell
death in vitro [33], the present study focused on iAs induced
adverse effects on apoptosis associated proteins and eval-
uated the role of simultaneous administration of ALA on
these proteins in vivo. Our results showed that cotreat-
ment with ALA decreased the number of TUNEL positive
cells and induced modulatory effects on apoptosis associ-
ated proteins (Bax, Bcl-2) in hippocampus of rats exposed
to iAs from PND 4 to 15. This modulatory inﬂuence of ALA
on apoptosis associated proteins as judged by the upregu-
lation of Bcl-2 and downregulation of Bax, suggests positive
inﬂuence of ALA on cell survival which could be attributed
to its ability to activate various neuroprotective and repair
pathways. One of the accepted phenomenon underlying
ALA induced amelioration is linked to its role in neu-
tralizing insult induced ROS and maintaining cortical and
S. Dixit et al. / Toxicology Reports 2 (2015) 78–87 85
Fig. 5. Immunoblots showing increased intensity of Bax expression in lanes 3 and 4 (A1) and Bcl-2 expression in lanes 5 and 6 (A2); Molecular weight
marker lane 0. Band of -tubulin as loading control (B1 and B2). Nc and Sc (lanes 1 and 2); iAs 1.5 and 2.0 (lanes 3 and 4); iAs 1.5 + ALA and 2.0 + ALA (lanes
5  and 6). Comparison by Kurskal–Wallis test followed by Bonferroni correction (pairwise comparison). * Sc vs iAs 1.5 (p < .001), # Sc vs iAs 2.0 (p < .001), **
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ippocampal GSH levels in compromised situations such as
schemia and exposure to toxic insults such as iAs [24,34].
 number of reports do suggest the role of antioxidant
upplementation in slowing and/or stopping the cells from
ying though the existent neuronal loss might persist [28].
The mitochondrial membrane potential is largely regu-
ated by the balancing equation of pro- and anti-apoptotic
roteins of BCl-2 family [35] and in turn, these proteins
re fairly sensitive to toxic insults [36,37]. Upregulation
f Bax mRNA and proteins has been reported to precede
ell death in selectively vulnerable neurons of hippocam-
us and substantia nigra following ischemic insults and
eurotoxin (MPTP) administration [38,39]. A number of
nvestigators [40] have proposed insult induced changes in
ax-BCl-2 genes, leading to distorted balance between acti-
ators and suppressants of cell death. The optimal balance
f these molecules in individual neurons has been reported
o act as the deciding factors in determining cell fate [41].
In the present study, ALA induced Bcl-2 upregulation
n association with decreased number of TUNEL positive
ells was observed in hippocampal subregions of animals
otreated with iAs and ALA. These observations were sup-
orted by the results of immunoblotting which showed
ubstantial increase in the intensity of Bcl-2 bands in the
LA cotreated animals, the intense expression of Bcl-2
ould be linked to ALA induced enhancement of Bcl-2 gene
xpression.
A number of studies have suggested the role of antioxi-
ants in modulation of Bax:Bcl-2 ratio by targeting diverse
ignaling pathways [42–44]. The earlier investigations,focusing on the effects of traumatic brain injury espe-
cially ischemic insults [37,45,46] have reported altered
Bax:Bcl-2 ratio as the underlying factor for increased apo-
ptosis. Das et al. [47] reported taurine induced signiﬁcant
reversal of Bcl-2 and Bax gene in liver of Swiss albino
male rats exposed to As (2 mg/kg bw) for 6 months. Das
and coworkers associated the ability of taurine to target
ROS production at mRNA level via JNK MAP  K signaling
pathway. Singh et al. [48] noted iAs (1, 10, 100 M,  48 h)
induced increase and decrease in Bax and Bcl-2 expression
respectively in murine embryonic maxillary mesenchyme
(MEMM)  cultures obtained from mice embryos (gd 13)
exposed on gd 7 and 8 to sodium arsenate (20 mg/kg
i.p.). Singh and coworkers further observed reversal of
arsenate mediated oxidative injury by pretreatment with
n-acetyl cystine (NAC). Lin et al. [43] studied the effect
of melatonin supplementation on iAs induced apoptosis
in CNS and noted upregulation of Bcl-2, active caspase-
3 and cytosolic cytochrome-c in the infused substantia
nigra and downregulation of dopamine in the nigrostriatal
dopaminergic system. Based on these observations, Lin and
coworkers suggested the therapeutic potential of mela-
tonin in reversing iAs induced inhibition of mitochondrial
and ER pathways. Pugazhenthi and coworkers [42] eval-
uated the role of antioxidant administration in oxidative
stress induced downregulation of CREB dependent Bcl-2
expression and they arrived at the conclusion that antiox-
idant mediated over-expression of CREB could result in
upregulation of Bcl-2, in turn laying the basis for cell sur-
vival. These above mentioned reports are suggestive of
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beneﬁcial effects of antioxidant supplementation based on
their ability to modulate expression of apoptosis associated
proteins under compromised situations.
The observations of our present study substantiate the
potential of ALA (antioxidant) in upregulation of BCl-2
expression and inﬂuencing the status of cell loss under
conditions of iAs induced neurotoxicity, thus providing pro-
tection to hippocampal neurons. ALA induced restoration
of the optimal level of Bax:Bcl-2 ratio (1:2) presumably is
the key factor in pushing the cells toward survival, thus
strongly supporting the view of earlier investigators [41]
pertaining to importance of maintained optimal balance of
Bcl-2 family proteins as an important step in ensuring cell
survival.
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